middle.news
Vectus Biosystems Nears $4.3M XORTX Deal, Advances Licensing Push
3:12pm on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
Vectus Biosystems Nears $4.3M XORTX Deal, Advances Licensing Push
3:12pm on Friday 30th of January, 2026 AEDT
Key Points
Binding agreement nearing completion with XORTX for VB4-P5 renal fibrosis compound
Deal valued at approximately A$4.3 million in shares and pre-funded warrants
Active licensing outreach for lead compound VB0004 and other drug candidates
Cash on hand at $330,000 with a fully drawn $450,000 loan facility
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
VBS
OPEN ARTICLE